L S Covey

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. ncbi request reprint Tobacco cessation among patients with depression
    L S Covey
    Department of Clinical Psychology in Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Prim Care 26:691-706. 1999
  2. pmc Divergence by ADHD subtype in smoking cessation response to OROS-methylphenidate
    Lirio S Covey
    New York State Psychiatric Institute, Columbia University Medical Center, Psychiatry, Clinical Therapeutics, New York, NY, USA
    Nicotine Tob Res 13:1003-8. 2011
  3. pmc OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences
    Lirio S Covey
    New York State Psychiatric Institute, Columbia University Medical Center, 1051 Riverside Drive, New York, NY 10032, United States
    Drug Alcohol Depend 110:156-9. 2010
  4. pmc A comparison of abstinence outcomes among gay/bisexual and heterosexual male smokers in an intensive, non-tailored smoking cessation study
    Lirio S Covey
    New York State Psychiatric Institute, Columbia University Medical Center, 1051 Riverside Drive, New York, NY 10032, USA
    Nicotine Tob Res 11:1374-7. 2009
  5. pmc Smoking cessation and inattention or hyperactivity/impulsivity: a post hoc analysis
    Lirio S Covey
    New York State Psychiatric Institute, Columbia University Medical Center, New York, NY 10032, USA
    Nicotine Tob Res 10:1717-25. 2008
  6. ncbi request reprint Smokers' response to combination bupropion, nicotine patch, and counseling treatment by race/ethnicity
    Lirio S Covey
    New York State Psychiatric Institute, New York City, New York, USA
    Ethn Dis 18:59-64. 2008
  7. ncbi request reprint A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse
    Lirio S Covey
    Smoking Cessation Program, New York State Psychiatric Institute, Columbia University Medical Center, New York, NY 10032, USA
    Addiction 102:1292-302. 2007
  8. pmc An exploration of site effects in a multisite trial of OROS-methylphenidate for smokers with attention deficit/hyperactivity disorder
    Lirio S Covey
    New York State Psychiatric Institute, Department of Psychiatry, Columbia University Medical Center, New York, USA
    Am J Drug Alcohol Abuse 37:392-9. 2011
  9. ncbi request reprint A randomized trial of sertraline as a cessation aid for smokers with a history of major depression
    Lirio S Covey
    New York State Psychiatric Institute, Columbia University, 1051 Riverside Drive, New York, NY 10032, USA
    Am J Psychiatry 159:1731-7. 2002
  10. ncbi request reprint Advances in non-nicotine pharmacotherapy for smoking cessation
    L S Covey
    New York State Psychiatric Institute, New York 10032, USA
    Drugs 59:17-31. 2000

Research Grants

Detail Information

Publications17

  1. ncbi request reprint Tobacco cessation among patients with depression
    L S Covey
    Department of Clinical Psychology in Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Prim Care 26:691-706. 1999
    ..Based on the author's experience with this population of smokers, recommendations for assessing smokers' vulnerability to depression, their level of nicotine dependence, and psychological and pharmacological aids for smokers are offered...
  2. pmc Divergence by ADHD subtype in smoking cessation response to OROS-methylphenidate
    Lirio S Covey
    New York State Psychiatric Institute, Columbia University Medical Center, Psychiatry, Clinical Therapeutics, New York, NY, USA
    Nicotine Tob Res 13:1003-8. 2011
    ..Divergence in treatment response is a potential indicator of qualitative heterogeneity. This study examined smoking cessation response by ADHD subtype to osmotic-release oral system methylphenidate (OROS-MPH)...
  3. pmc OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences
    Lirio S Covey
    New York State Psychiatric Institute, Columbia University Medical Center, 1051 Riverside Drive, New York, NY 10032, United States
    Drug Alcohol Depend 110:156-9. 2010
    ..To explore racial/ethnic difference in OROS-methylphenidate (OMPH) efficacy when added to nicotine patch and counseling for treating nicotine dependence among smokers with attention deficit hyperactivity disorder (ADHD)...
  4. pmc A comparison of abstinence outcomes among gay/bisexual and heterosexual male smokers in an intensive, non-tailored smoking cessation study
    Lirio S Covey
    New York State Psychiatric Institute, Columbia University Medical Center, 1051 Riverside Drive, New York, NY 10032, USA
    Nicotine Tob Res 11:1374-7. 2009
    ..This study examined abstinence outcome in response to a high intensity smoking cessation program not specifically tailored to LGB smokers...
  5. pmc Smoking cessation and inattention or hyperactivity/impulsivity: a post hoc analysis
    Lirio S Covey
    New York State Psychiatric Institute, Columbia University Medical Center, New York, NY 10032, USA
    Nicotine Tob Res 10:1717-25. 2008
    ..Combined bupropion and nicotine patch treatment appears to be helpful for smokers with inattention but not smokers with hyperactivity/inattention symptoms. The reasons for this divergent treatment response warrant further investigation...
  6. ncbi request reprint Smokers' response to combination bupropion, nicotine patch, and counseling treatment by race/ethnicity
    Lirio S Covey
    New York State Psychiatric Institute, New York City, New York, USA
    Ethn Dis 18:59-64. 2008
    ..Evidence on how to tailor nicotine dependence treatment to specific race/ethnic groups is limited. The present study investigated responses to established smoking cessation treatments among African American, Hispanic, and White adults...
  7. ncbi request reprint A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse
    Lirio S Covey
    Smoking Cessation Program, New York State Psychiatric Institute, Columbia University Medical Center, New York, NY 10032, USA
    Addiction 102:1292-302. 2007
    ..To investigate the efficacy of maintenance treatment with bupropion and/or nicotine gum for reducing smoking relapse...
  8. pmc An exploration of site effects in a multisite trial of OROS-methylphenidate for smokers with attention deficit/hyperactivity disorder
    Lirio S Covey
    New York State Psychiatric Institute, Department of Psychiatry, Columbia University Medical Center, New York, USA
    Am J Drug Alcohol Abuse 37:392-9. 2011
    ....
  9. ncbi request reprint A randomized trial of sertraline as a cessation aid for smokers with a history of major depression
    Lirio S Covey
    New York State Psychiatric Institute, Columbia University, 1051 Riverside Drive, New York, NY 10032, USA
    Am J Psychiatry 159:1731-7. 2002
    ..Specifically, sertraline's efficacy for smoking abstinence and its effects on withdrawal symptoms were evaluated...
  10. ncbi request reprint Advances in non-nicotine pharmacotherapy for smoking cessation
    L S Covey
    New York State Psychiatric Institute, New York 10032, USA
    Drugs 59:17-31. 2000
    ..Thus, available evidence indicates that non-nicotine drug treatments offer a promising panoply of therapeutic strategies for the addicted smoker...
  11. ncbi request reprint Current perspectives on smoking cessation among substance abusers
    Maria A Sullivan
    Department of Psychiatry, College of Physicians and Surgeons, New York State Psychiatric Institute at Columbia University, NY 10032, USA
    Curr Psychiatry Rep 4:388-96. 2002
    ..Smoking cessation is indicated for substance dependent persons already in recovery and may protect against relapse to the illicit drug of abuse...
  12. ncbi request reprint Nicotine dependence: the role for antidepressants and anxiolytics
    Maria A Sullivan
    New York State Psychiatric Institute, New York 10032, USA
    Curr Opin Investig Drugs 3:262-71. 2002
    ..The norepinephrinergic effects of nicotine may account for increased attentiveness and improved performance in repetitive tasks, while its anxiolytic effects are likely mediated through GABA and the endorphins...
  13. ncbi request reprint Smoking cessation and the course of major depression: a follow-up study
    A H Glassman
    Department of Clinical Psychopharmacology, New York State Psychiatric Institute, 1051 Riverside Drive, 10032, New York, NY, USA
    Lancet 357:1929-32. 2001
    ..However, these studies confound effects of abstinence and history of depression. We aimed to assess whether there is an increased risk of depression and for how long that increase lasts...
  14. ncbi request reprint History of depression and smoking cessation: a rejoinder
    Lirio S Covey
    Nicotine Tob Res 8:315-9. 2006
  15. pmc Response: getting tough with smoking
    Lirio S Covey
    Sci Pract Perspect 2:40-2. 2003
  16. ncbi request reprint Lack of effect of D2 dopamine receptor TaqI A polymorphism on smoking cessation
    Ivan Berlin
    Departement de Pharmacologie, Groupe Hospitalier Universitaire Pitié Salpêtrière, Paris, France
    Nicotine Tob Res 7:725-8. 2005
    ..The present study reports on results of a similar smoking cessation study and uses the same methods and data analysis in a larger number of smokers. It fails to replicate the effect of DRD2 TaqI A polymorphism on smoking cessation...
  17. ncbi request reprint Pre-cessation depressive mood predicts failure to quit smoking: the role of coping and personality traits
    Ivan Berlin
    Groupe Hospitalier Universitaire Pitié Salpêtrière, Université Pierre and Marie Curie Paris 6 and INSERM U 677, Paris, France
    Addiction 101:1814-21. 2006
    ..To examine whether mood, personality and coping predict smoking cessation and whether the associations of personality and coping are mediated through depressed mood...

Research Grants8

  1. MAINTENANCE TREATMENT FOR PREVENTION OF SMOKING RELAPSE
    Lirio Covey; Fiscal Year: 2004
    ..abstract_text> ..